Partnering with CROs and using a blinded independent central review can increase trial success.
John F. Tomera
Advertisement
Articles by John F. Tomera
How independent endpoint assessment committees can overcome imaging limitations.
Advertisement
Latest Updated Articles
Enrollment: More Than NumbersPublished: February 1st 2012 | Updated:
A Team ApproachPublished: May 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
3
Rethinking Operational Models to Reduce Site Burden in 2026
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5